AP2007004151A0 - Adjuvant composition comprising aluminium phosphate and 3D-MPL - Google Patents

Adjuvant composition comprising aluminium phosphate and 3D-MPL

Info

Publication number
AP2007004151A0
AP2007004151A0 AP2007004151A AP2007004151A AP2007004151A0 AP 2007004151 A0 AP2007004151 A0 AP 2007004151A0 AP 2007004151 A AP2007004151 A AP 2007004151A AP 2007004151 A AP2007004151 A AP 2007004151A AP 2007004151 A0 AP2007004151 A0 AP 2007004151A0
Authority
AP
ARIPO
Prior art keywords
mpl
adjuvant composition
aluminium phosphate
aluminium
phosphate
Prior art date
Application number
AP2007004151A
Other languages
English (en)
Inventor
Derek O'hagan
Original Assignee
Norvatis Vaccines And Diagnost
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norvatis Vaccines And Diagnost filed Critical Norvatis Vaccines And Diagnost
Publication of AP2007004151A0 publication Critical patent/AP2007004151A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AP2007004151A 2005-02-16 2006-02-16 Adjuvant composition comprising aluminium phosphate and 3D-MPL AP2007004151A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65374105P 2005-02-16 2005-02-16
PCT/GB2006/000557 WO2006087563A2 (en) 2005-02-16 2006-02-16 Adjuvant composition comprising aluminium phosphate and 3d-mpl

Publications (1)

Publication Number Publication Date
AP2007004151A0 true AP2007004151A0 (en) 2007-10-31

Family

ID=36916823

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004151A AP2007004151A0 (en) 2005-02-16 2006-02-16 Adjuvant composition comprising aluminium phosphate and 3D-MPL

Country Status (18)

Country Link
US (1) US20090214592A1 (pt)
EP (1) EP1850871A2 (pt)
JP (1) JP2008530195A (pt)
KR (1) KR20070110513A (pt)
CN (1) CN101146551A (pt)
AP (1) AP2007004151A0 (pt)
AU (1) AU2006215419B2 (pt)
BE (1) BE1016991A6 (pt)
BR (1) BRPI0608430A2 (pt)
CA (1) CA2598079A1 (pt)
EA (1) EA012212B1 (pt)
IL (1) IL185346A0 (pt)
MX (1) MX2007009961A (pt)
NO (1) NO20074679L (pt)
NZ (1) NZ560930A (pt)
SG (1) SG160328A1 (pt)
WO (1) WO2006087563A2 (pt)
ZA (1) ZA200707089B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1909830T3 (da) * 2005-08-02 2011-12-19 Novartis Vaccines & Diagnostic Formindskelse af interferens mellem olieholdige adjuvanser og antigener indeholdende overfladeaktivt middel
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
JP5814507B2 (ja) * 2006-09-07 2015-11-17 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
DK2403507T3 (en) * 2009-03-05 2018-06-06 Jenny Colleen Mccloskey TREATMENT OF INFECTION
CN102526724B (zh) * 2011-01-14 2015-07-22 四川大学 氢氧化铝凝胶-多糖复合免疫佐剂及其制备方法和用途
EP2726097A4 (en) * 2011-07-01 2015-03-11 Univ California HERPES VIRUS VACCINE AND METHOD OF USE
CN103330936B (zh) * 2013-07-18 2016-01-27 北京民海生物科技有限公司 一种磷酸铝佐剂原位法制备乙肝疫苗的方法
CN106535929A (zh) * 2014-03-25 2017-03-22 美国政府陆军部 增强铝盐吸附疫苗的免疫刺激效力的方法
MX2022002980A (es) 2019-09-16 2022-04-06 Amgen Inc Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
CN120404993B (zh) * 2025-07-03 2025-10-03 成都迈科康生物科技有限公司 一种检测样本中mpl的方法及其相关应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5084282A (en) * 1990-08-16 1992-01-28 J.C. Steele & Sons Apparatus for forming bricks having a textured edge
EP0515704B1 (de) * 1991-04-26 1993-01-20 Hans Lingl Anlagenbau und Verfahrenstechnik GmbH & Co. KG Verfahren und Vorrichtung zum Kerben eines Tonstrangstückes
US6620414B2 (en) * 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
US5776468A (en) * 1993-03-23 1998-07-07 Smithkline Beecham Biologicals (S.A.) Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
US6488934B1 (en) * 1995-02-25 2002-12-03 Smithkline Beecham Biologicals S.A. Hepatitis B vaccine
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
US20010053365A1 (en) * 1995-04-25 2001-12-20 Smithkline Beecham Biologicals S.A. Vaccines
GB9718901D0 (en) * 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
KR100629028B1 (ko) * 1998-10-16 2006-09-26 글락소스미스클라인 바이오로지칼즈 에스.에이. 애쥬번트 시스템 및 백신
GB9822714D0 (en) * 1998-10-16 1998-12-09 Smithkline Beecham Sa Vaccines
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US7030094B2 (en) * 2002-02-04 2006-04-18 Corixa Corporation Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21

Also Published As

Publication number Publication date
BE1016991A6 (fr) 2007-11-06
MX2007009961A (es) 2008-01-29
US20090214592A1 (en) 2009-08-27
JP2008530195A (ja) 2008-08-07
EA012212B1 (ru) 2009-08-28
ZA200707089B (en) 2008-11-26
WO2006087563A3 (en) 2007-03-15
EP1850871A2 (en) 2007-11-07
AU2006215419B2 (en) 2012-03-08
EA200701743A1 (ru) 2008-02-28
AU2006215419A1 (en) 2006-08-24
NO20074679L (no) 2007-09-13
IL185346A0 (en) 2008-02-09
CN101146551A (zh) 2008-03-19
KR20070110513A (ko) 2007-11-19
SG160328A1 (en) 2010-04-29
CA2598079A1 (en) 2006-08-24
NZ560930A (en) 2011-06-30
WO2006087563A2 (en) 2006-08-24
BRPI0608430A2 (pt) 2009-12-29

Similar Documents

Publication Publication Date Title
ZA200707089B (en) Adjuvant composition comprising aluminium phosphate and 3D-MPL
IL191287A0 (en) Atorvastatin formulation
EP1846372A4 (en) COMPOUNDS FOR INFLAMMATORY AND IMMUNE CONDITIONS
IL184756A0 (en) Compounds for inflammation and immune-related uses
GB0525314D0 (en) Method and composition
IL185223A0 (en) Compounds and uses thereof
GB0619096D0 (en) Polishing composition and polishing method
EP1726304A4 (en) COMPOSITION CONTAINING SOLIFENACIN
ZA200802969B (en) Composition and method
ZA200608311B (en) Composition comprising statins
SG131098A1 (en) Polishing composition and polishing method
TWI365899B (en) Adhesive composition and method
GB2428678B (en) Glyceride compounds and uses thereof
EP1923446A4 (en) REFRIGERANT COMPOSITION
ZA200608935B (en) Methods and compositions for epilation
ZA200801208B (en) Anti-malarial composition
GB0424051D0 (en) Compounds and compositions
GB0522655D0 (en) Composition and method
EP1930391A4 (en) REFRIGERANT COMPOSITION
GB0501348D0 (en) Compositions and methods
GB0515648D0 (en) Improvements in or relating to disc brakes
GB0622048D0 (en) Surface enhancement formulation
GB0804899D0 (en) Compound composition and use
GB2431929B (en) Surface enhancement formulation
ZA200706565B (en) Compounds for inflammation and immune-related uses